Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Other Non-Current Assets: 2018-2021

Historic Other Non-Current Assets for Black Diamond Therapeutics (BDTX) over the last 3 years, with Sep 2021 value amounting to $1.2 million.

  • Black Diamond Therapeutics' Other Non-Current Assets changed negligibly% to $1.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.2 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $1.2 million for FY2020, which is 46.90% down from last year.
  • Per Black Diamond Therapeutics' latest filing, its Other Non-Current Assets stood at $1.2 million for Q3 2021, which was down 0.00% from $1.2 million recorded in Q2 2021.
  • Black Diamond Therapeutics' 5-year Other Non-Current Assets high stood at $2.3 million for Q4 2019, and its period low was $8,000 during Q4 2018.
  • For the 3-year period, Black Diamond Therapeutics' Other Non-Current Assets averaged around $863,800, with its median value being $1.2 million (2021).
  • As far as peak fluctuations go, Black Diamond Therapeutics' Other Non-Current Assets skyrocketed by 28,687.50% in 2019, and later slumped by 46.90% in 2020.
  • Quarterly analysis of 4 years shows Black Diamond Therapeutics' Other Non-Current Assets stood at $8,000 in 2018, then soared by 28,687.50% to $2.3 million in 2019, then slumped by 46.90% to $1.2 million in 2020, then remained steady at $1.2 million in 2021.
  • Its Other Non-Current Assets stands at $1.2 million for Q3 2021, versus $1.2 million for Q2 2021 and $1.2 million for Q1 2021.